A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
作者信息
Schmid J R, Hanna C
出版信息
J Pharmacol Exp Ther. 1967 May;156(2):331-8.
PMID:4381702
Abstract
摘要
相似文献
1
A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
J Pharmacol Exp Ther. 1967 May;156(2):331-8.
2
Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
Arch Int Pharmacodyn Ther. 1970 Jun;185(2):228-33.
3
Antiarrhythmic actions of a new coronary vasodilator agent, iproveratril.
J Ark Med Soc. 1967 May;63(12):455.
4
Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Arzneimittelforschung. 1968 Jul;18(7):845-50.
5
[Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
Arzneimittelforschung. 1968 Oct;18(10):1274-8.
6
[Antiarrhythimic properties of ethmozine].
Farmakol Toksikol. 1970;33(6):693-7.
7
Evaluation of antiarrhythmic and other cardiac activities in some newly synthesized quinazolone compounds.
Arch Int Pharmacodyn Ther. 1972;198(1):94-106.
8
[The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
Arzneimittelforschung. 1970 Sep;20:Suppl 9a:1285+.
9
Experimental evaluation of antiarrhythmic drugs in the guinea pig.
Biomedicine. 1973 Jul 20;19(7):308-13.
10
[Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
Farmakol Toksikol. 1969 Sep-Oct;32(5):566-70.
引用本文的文献
1
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy.
Pharmaceuticals (Basel). 2023 Jul 7;16(7):977. doi: 10.3390/ph16070977.
2
A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.
Br J Pharmacol. 1970 Aug;39(4):675-87. doi: 10.1111/j.1476-5381.1970.tb09893.x.
3
[Prevention of coplications in th combination of suprarenin infiltration with halothane and barbiturate anesthesia].
Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1970;195(4):298-312.
4
Effect of verapamil in obstructive airways disease.
Eur J Clin Pharmacol. 1974;7(1):61-4. doi: 10.1007/BF00614392.
5
Verapamil in the treatment of paroxysmal supraventricular tachycardia.
Postgrad Med J. 1974 Jul;50(585):447-53. doi: 10.1136/pgmj.50.585.447.
6
General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.
Naunyn Schmiedebergs Arch Pharmakol. 1971;269(2):219-31. doi: 10.1007/BF01003039.
7
Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
Experientia. 1971 Jun;27(6):666-7. doi: 10.1007/BF02136950.
8
Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.
Br J Pharmacol. 1970 May;39(1):128-38. doi: 10.1111/j.1476-5381.1970.tb09562.x.
9
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
Drugs. 1987 Sep;34(3):311-49. doi: 10.2165/00003495-198734030-00002.
10
What is the solution to sudden cardiac death: calcium modulation or arrhythmia clinics?
Cardiovasc Drugs Ther. 1987 Dec;1(4):335-42. doi: 10.1007/BF02209072.
Zotero 插件